Yasuhiro Natori

A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing <i>Escherichia coli</i> O157:H7

Kiyotaka Nishikawa, Koji Matsuoka, Eiji Kita et al. · Proceedings of the National Academy of Sciences · 2002 · 198 citations

Life Sciences, Infectious Diseases, Pharmacology +16

Oral Therapeutic Agents with Highly Clustered Globotriose for Treatment of Shiga Toxigenic<i>Escherichia coli</i>Infections

Miho Watanabe, Koji Matsuoka, Eiji Kita et al. · The Journal of Infectious Diseases · 2004 · 120 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +16

Biochemical and Molecular Characterization of a Novel Choline-specific Glycerophosphodiester Phosphodiesterase Belonging to the Nucleotide Pyrophosphatase/Phosphodiesterase Family

Hideki Sakagami, Junken Aoki, Yumiko Natori et al. · Journal of Biological Chemistry · 2005 · 113 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +13

Erythromycin Inhibition of Lipopolysaccharide-Stimulated Tumor Necrosis Factor Alpha Production by Human Monocytes in Vitro

Yukiko Iino, Minoru Toriyama, Yasuhiro Natori et al. · Annals of Otology Rhinology & Laryngology · 1992 · 105 citations

Medicine, Immunology, Pharmacology +11

Identification of the Optimal Structure Required for a Shiga Toxin Neutralizer with Oriented Carbohydrates to Function in the Circulation

Kiyotaka Nishikawa, Koji Matsuoka, Miho Watanabe et al. · The Journal of Infectious Diseases · 2005 · 95 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17